Akari Therapeutics Plc
through Jun 3, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Oct 24, 2025 · D | Jun 3, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,250,000 | $5,500,000 | $-750,000 |
| Reported amount sold | $6,250,000 | $1,833,333 | $-4,416,667 |
| Reported investor count | — | 6 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001493152-25-019187 · Later SEC source: 0001493152-26-027117
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $5,500,000
- Reported amount sold
- $1,833,333
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001493152-26-027117D · Jun 3, 2026 · Other Health CareOffering: $5,500,000Sold: $1,833,333
-
0001493152-25-019187D · Oct 24, 2025 · Other Health CareOffering: $6,250,000Sold: $6,250,000